(Q44010395)

English

Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB.

scientific article published on 7 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

1 reference

based on heuristic

inferred from title

diabetic cardiomyopathy

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Yuehui Wang

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Weixia Sun

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Bing Du

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Xiao Miao

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Yang Bai

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ying Xin

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Yi Tan

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Wenpeng Cui

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Bin Liu

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Taixing Cui

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Yaowen Fu

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Lu Cai

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

7 December 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

304

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

H567-78

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23220333%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Oxidative stress and diabetic cardiomyopathy: a brief review

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Increasing expression of heme oxygenase-1 by proteasome inhibition protects astrocytes from heme-mediated oxidative injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Structure and functions of the 20S and 26S proteasomes

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Oxidative stress: a key contributor to diabetic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Role of nuclear factor-kappa B activation in acute ischaemia-reperfusion injury in myocardium

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Enhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

A proteasome inhibitor effectively prevents mouse heart allograft rejection

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Proteasome inhibitor MG132 inhibits angiogenesis in pancreatic cancer by blocking NF-kappaB activity.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Inhibitory kappa B kinase-beta is a target for specific nuclear factor kappa B-mediated delayed cardioprotection.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

The ubiquitin-proteasome system and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase C/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Mechanism of the Nrf2/Keap1/ARE signaling system.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Proteasome inhibition during myocardial infarction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Development of late-stage diabetic nephropathy in OVE26 diabetic mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00650.2012

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44010395&oldid=2105612889"